In vitro correction of ARSA deficiency in human skin fibroblasts from metachromatic leukodystrophy patients after treatment with microencapsulated recombinant cells.
Metachromatic leukodystrophy (MLD) is an autosomal recessive disorder due to arylsulfatase A (ARSA) deficiency that affects primarily the central nervous system. Ongoing treatments include enzyme replacement therapy and bone marrow transplantation, both limited in their effects due to the blood-brain barrier. An alternative approach would be the in situ implantation of encapsulated cells over expressing ARSA. Based on that, we tested the ability of encapsulated BHK cells over expressing ARSA to correct the enzyme deficiency in MLD patients' fibroblasts. Three groups were analyzed: fibroblasts treated with ARSA-over expressing BHK cells (rBHK) trapped in alginate capsules (capsules group), fibroblasts treated with supernatant of non-encapsulated rBHK (uptake control) and fibroblasts treated with empty capsules (empty group). Untreated and normal fibroblasts were used as controls. rBHK obtained by clone selection after non-viral transfection with pTARSA-CMV2. ARSA activity was measured after 1, 2, 3 and 4 weeks of treatment and beta-gal was used as reference enzyme. Statistical analysis was performed using ANOVA and Tukey's test. Normal fibroblasts showed ARSA activity of 23.9 + /- 2.01 nmol/h/mg of protein, whereas untreated MLD fibroblasts had the low ARSA activity (2.22 + /- 0.17). In the empty group, ARSA activity was equal to that of untreated fibroblasts (2.71 + /- 0.34). Capsules and uptake control groups showed higher enzymatic activity levels, compared to MLD untreated, 23.42 + /- 6.39 and 42.35 + /- 5.20, respectively (p < 0.01 for all groups). Encapsulated rBHK clones show potential as a new therapeutic strategy for the treatment of MLD, reaching normal enzyme levels in human MLD fibroblasts.
Lagranha
Valeska Lizzi
VL
Postgraduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil. valleska@gmail.com
Baldo
Guilherme
G
de Carvalho
Talita Giacomet
TG
Burin
Maira
M
Saraiva-Pereira
Maria Luiza
ML
Matte
Ursula
U
Giugliani
Roberto
R
D000704:Analysis of Variance; D002214:Capsules; D017690:Cell Transplantation / Q000379:methods*; D002478:Cells, Cultured; D002553:Cerebroside-Sulfatase / Q000172:deficiency / Q000235:genetics*; D005347:Fibroblasts / Q000201:enzymology*; D005818:Genetic Engineering; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors / Q000235:genetics / Q000627:therapeutic use*; D006801:Humans; D020007:Implants, Experimental; D007668:Kidney / Q000166:cytology; D007966:Leukodystrophy, Metachromatic / Q000201:enzymology / Q000235:genetics / Q000628:therapy*; D018709:Statistics, Nonparametric; D019076:Transgenes / Q000235:genetics
D002214:Capsules; D002553:Cerebroside-Sulfatase
J Mol Cell Cardiol. 2003 Jul;35(7):823-31
12818573
J Biol Chem. 1989 May 15;264(14):8222-9
2722778
Glia. 2006 Mar;53(4):372-81
16288467
Mol Cell Biol. 1987 Nov;7(11):4125-9
2828927
J Pediatr. 2001 Apr;138(4):539-47
11295718
Virchows Arch. 2001 Jul;439(1):90-6
11499846
J Gene Med. 2005 Nov;7(11):1482-91
15966019
Exp Neurol. 2000 Dec;166(2):276-86
11085893
J Virol. 2001 Dec;75(24):12382-92
11711628
Acta Neuropathol. 2004 Oct;108(4):261-71
15322834
J Neurooncol. 2006 May;78(1):31-9
16598433
Mol Genet Metab. 2001 Mar;72(3):199-208
11243725
J Biol Chem. 1989 Jan 15;264(2):1252-9
2562955
Exp Neurol. 2008 Jan;209(1):82-8
17963752
Carcinogenesis. 2003 Oct;24(10):1625-35
12869421
Gene Ther. 2003 Aug;10(16):1275-81
12883523
Tohoku J Exp Med. 2006 May;209(1):23-32
16636519
Neuro Oncol. 2001 Jul;3(3):201-10
11465401
Hum Gene Ther. 2004 Oct;15(10):968-75
15585112
Am J Pathol. 1973 Oct;73(1):59-80
4201373
Nat Med. 2001 Mar;7(3):310-6
11231629
Cell Transplant. 1999 Jul-Aug;8(4):427-30
10478724
Hum Mol Genet. 2005 May 1;14(9):1139-52
15772092
J Postgrad Med. 2003 Apr-Jun;49(2):127-31
12867687
Mol Ther. 2005 May;11(5):754-62
15851014
Anticancer Res. 2002 Nov-Dec;22(6A):3325-30
12530082
J Gene Med. 2004 Apr;6(4):395-404
15079814
Clin Chim Acta. 1987 Apr 30;164(2):171-80
2885112
J Neurosci Methods. 2007 Apr 15;161(2):223-33
17204333
Hum Gene Ther. 2007 Sep;18(9):821-36
17845130
J Biol Chem. 1951 Nov;193(1):265-75
14907713
Nat Rev Genet. 2002 Dec;3(12):954-66
12459725
J Neurol Sci. 2007 Apr 15;255(1-2):7-16
17341424
J Inherit Metab Dis. 2001 Apr;24(2):245-50
11405343
Hum Gene Ther. 1992 Aug;3(4):371-9
1525210